Prof Tan’s career spans across public sector, corporate and industry start-ups. He spent more than a decade between a US corporate and biotech start-up.
Prof Tan’s career in A*STAR started in 2009 and he spent his time across the Science and Engineering Research Council, Biomedical Research Council as a well as the Innovation and Enterprise Division. This involves the executive leadership and governance of the 17 Research Institutes as well as National Platforms Diagnostic Development Hub (DxDHub) and Experimental Drug Development Centre (EDDC).
Professor Tan has also promoted international research, innovation and enterprise partnership between Singapore, A*Star and its key scientific international partners.
He is a speaker at international conferences and advises academic, corporate and not for profit organisations for wide range of topics.
Professor Tan is Adjunct Professor at Duke-NUS Medical School Singapore.
Professor Tan was a former Nominated Member of Parliament of Singapore. He is the receipent of the Singapore Public Administration Medal (Silver) and Singapore (Covid-19) Public Administration Medal (Silver). He is also a recipient of Friend of Labour Award.
Professor Tan is a board member of Singapore Eye Research Institute (SERI) and member of SERI's Incubator Advisory Board. He is a council member of the Singapore Medical Association (SMA), as well as a board director for SMA Pte Ltd. He is also the Chairman of the NUS Medicine Industry Advisory Board for Non-Clinical Post Graduate Coursese. Prof Tan is also the Chairman of Unlocking ADHD Ltd.
Professor Tan graduated with MBBS from National University of Singapore (NUS), and attained his MBA from Warwick University, UK. He attended the Stanford Executive Programme at the Stanford Graduate School Business, and was awarded a certificate of completion for the Senior Fellowship in Public Service Programme, Lee Kuan Yew School of Public Policy. Prof Tan also attended the Executive Leadership Programme from the Singapore Civil Service College. He is an affiliate member of the Faculty of Pharmaceutical Medicine, Royal College of Physicians, UK. He is a registered medical practitioner with the Singapore Medical Council and the Hong Kong Medical Council.
陈教授的职业生涯横跨公共部门、企业和行业初创公司等多个领域。他曾在一家美国企业和一家生物科技初创企业就职超过十年时间。
陈教授于2009年加入新加坡科技研究局（A*STAR, 简称“新科研”）。在此期间，他曾在科学工程研究理事会（SERC）、生物医药研究理事会（BMRC）以及创新与企业部（Innovation and Enterprise Division）任职，负责管理和领导17个研究院及国家平台（诊断发展中心和实验药物开发中心）。陈教授于2023年至2025年期间担任BMRC副总裁。
陈教授致力于推动新加坡、新科研及其全球主要科研伙伴在国际研究、创新和企业等领域的合作。他促成了新加坡与中国、德国、韩国、日本和新西兰之间的双边研究合作项目，曾多次在国际会议上就医疗技术、健康科技中的人工智能等主题发表演讲，并为学术机构、企业和非营利组织提供多领域的咨询。
陈教授目前担任南洋理工大学李光前医学院和杜克-新加坡国立大学医学院副教授。
陈教授曾被提名为新加坡国会管委议员，并荣获新加坡公共⾏政（银）奖章、新加坡 应对冠病公共⾏政（银）奖章以及新加坡“劳工之友”奖。
陈教授在新加坡多个国家委员会任职，包括新加坡先进细胞治疗与研究中心 (ACTRIS) 和新加坡癌症转化联盟 (STCC) 董事会监督委员会成员、新加坡眼科研究所 (SERI) 董事会成员及该研究所眼科技术孵化器二期项目的孵化器咨询委员会成员。他同时也是新加坡医学会 (SMA) 理事会成员、 SMA私人有限公司董事以及Unlocking ADHD有限公司董事长。
陈教授毕业于新加坡国立大学（内外全科医学士学位），并在英国华威大学获得了工商管理硕士学位。他曾就读于斯坦福大学商学院的斯坦福高管课程，并获颁新加坡李光耀公共政策学院公共服务高级研究员项目结业证书，还曾参加新加坡公共服务学院的高管领导力课程。陈教授是英国皇家内科医师学会药学院附属成员，以及新加坡医学委员会和香港医务委员会的注册执业医师。